Ignite Creation Date:
2024-10-26 @ 3:37 PM
Last Modification Date:
2024-10-26 @ 3:37 PM
Study NCT ID:
NCT06540378
Status:
COMPLETED
Last Update Posted:
None
First Post:
2024-07-30
Brief Title:
Stiripentol for the Treatment of Refractory Status Epilepticus
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Stiripentol for the Treatment of Refractory Status Epilepticus
Status:
COMPLETED
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The investigators retrospectively analyzed all patients who were admitted to the Department of Neurology at Marburg University Hospital between 2013 and 2023 with a diagnosis of super-refractory status epilepticus and who received additional treatment of SE with STP All patients who received STP during the SE were included regardless of previous medication
Detailed Description:
The investigators retrospectively analyzed all patients who were admitted to the Department of Neurology University Hospital Marburg Germany between 2013 and 2023 with a diagnosis of status epilepticus who received additional treatment of SE with STP They were able to identify 25 patients who received STP as add on therapy All these patients suffered from RSE or SRSE Since there was no SOP or treatment algorithm available they have listed the individual treatment regimens in Table 2 5 of these patients were previously published in a case series Strzelczyk et al 2015
Treatment success was defined as continuous interruption of the SE Descriptive statistics are reported as absolute numbers and percentages mean standard deviation SD or median median absolute deviation
The study was approved by the local IRB
Treatment success was defined as continuous interruption of the SE Descriptive statistics are reported as absolute numbers and percentages mean standard deviation SD or median median absolute deviation
The study was approved by the local IRB
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None